Governance Luxempart

LXMPR

LU2605908552

Investment Management & Fund Operators

End-of-day quote LUXEMBOURG S.E. Other stock markets 23/01/2026			5-day change	1st Jan Change
63.50 ^EUR	-3.79%		-0.78%	+0.79%

12-19	Luxempart to Become Majority Shareholder in Valeara	MT
12-04	Luxempart completed the acquisition of The ASSMANN Group from Stephan Assmann.	CI

Executive Committee: Luxempart

Manager

Positions heldSince

John Penning

54 year

Chief Executive Officer

26/04/2020

Laeticia Hennequin-Langer

Comptroller/Controller/Auditor

31/12/2012

Jemuel Durand Durand

Chief Investment Officer

31/12/2024

Evelina Maron

Human Resources Officer

31/12/2021

Lionel de Hemptinne

Director of Finance/CFO

31/03/2022

Philippe Liska

Comptroller/Controller/Auditor

31/12/2001

Betty Kizimalé-Grant

General Counsel

31/12/2018

Composition of the Board of Directors: Luxempart

Director

CommitteesSince

François Gillet

66 year

Chairman

23/04/2023

Jacquot Schwertzer

70 year

Audit Committee
Executive Committee	26/04/2015
Compensation Committee	26/04/2015
Nominating Committee	26/04/2015

Frank Donck

61 year

Audit Committee	26/04/2020
Nominating Committee	13/05/2014
Compensation Committee Chair	31/08/2024
Nominating Committee Chair	31/08/2024

Owen Tesch

Audit Committee	23/04/2023
Executive Committee	23/04/2023
Compensation Committee	23/04/2023
Nominating Committee	23/04/2023

Jacques Elvinger

68 year

Compensation Committee Chair
Nominating Committee Chair

Jürgen Vanselow

66 year

Compensation Committee	23/04/2017
Nominating Committee	23/04/2017

John Penning

54 year

Executive Committee

30/04/2017

Kay Ashton

61 year

Audit Committee Chair

Valentin Cogels

Director/Board Member	27/04/2025
Independent Dir/Board Member	27/04/2025

Grégoire Chertok

59 year

Director/Board Member	23/04/2016
Independent Dir/Board Member	23/04/2016

Madeleine Jahr

46 year

Director/Board Member	29/04/2018
Independent Dir/Board Member	29/04/2018

Xavier Coirbay

60 year

Director/Board Member

23/04/2023

Former Officers and Directors: Luxempart

Insider

Positions held

SinceUntil

Michèle Detaille

Director/Board Member	29/04/2012	24/04/2025
Independent Dir/Board Member	29/04/2012	28/04/2024

François Tesch

Director/Board Member	-	-
Chief Executive Officer	28/02/2010	-
Chairman	14/09/1992	23/04/2023

Pierre Drion

Director/Board Member	27/04/2008	23/04/2023
Independent Dir/Board Member	27/04/2008	23/04/2023

Florian Herger

Chief Investment Officer

31/12/2021

Olaf Kordes

Director/Board Member	26/04/2020	-
Chief Executive Officer	26/04/2020	-

Ernst-Wilhelm Contzen

Director/Board Member	15/07/2010	29/04/2018
Independent Dir/Board Member	-	29/04/2018

René Steichen

Director/Board Member

01/01/2009

Pascale Finck

Chief Administrative Officer	31/12/1991	-
Corporate Secretary	20/12/2013	-

Gaston Schwertzer

Chairman	15/07/2010	-
Founder	24/04/1988	-

François N. Wagener

Director/Board Member

15/07/2010

André Elvinger

Director/Board Member

15/07/2010

Giusseppe Santino

Director/Board Member	15/07/2010	-
Corporate Officer/Principal	-	-

Sebastian Reppegather

Chief Investment Officer	-	-
Corporate Officer/Principal	-	-

Thomas Rau

Chief Investment Officer

Céline Campi-Blain

Human Resources Officer

Age distribution of managers

Parity Men Women

Male	14
Female	6

Of which Executive Committee

Male	4
Female	3

Of which Directors

Male	10
Female	2

Luxempart SA is a Luxembourg-based investment company which invests in listed and private equity, as well as in private equity funds. The Company is active in Luxembourg, Belgium, France, Italy and Germany, where it manages a portfolio of listed and unlisted companies. Through Luxempart Capital Partners and Indufin Capital Partners (ICP), Luxempart also runs private equity activities. ICP is a joint-venture with the Belgian family holding Eik NV. The Company holds stakes in a number of private companies, including SES, RTL Group, Atenor, Foyer Finance, Foyer SA, SEO, PNE Wind, Pescanova, Mirato, Indufin Capital Partners - ICP Sicar, IEE, Quip, DS Care, Ekkio Capital, Thrombogenics, IP Sante domicile, Octopede Fonds private equity, among others. It also holds a majority stake in Euphaco (ABC Chemical).

Employees

Sector

Investment Management & Fund Operators

Calendar

03-26 - Q4 2025 Earnings Release (Projected)

More about the company